Malignant neoplasm of overlapping sites of small intestine
ICD-10 C17.8 is a billable code used to indicate a diagnosis of malignant neoplasm of overlapping sites of small intestine.
C17.8 refers to malignant neoplasms that arise from overlapping sites within the small intestine, which includes the duodenum, jejunum, and ileum. These tumors can present as adenocarcinomas, lymphomas, or neuroendocrine tumors, among others. The overlapping site designation indicates that the tumor cannot be precisely classified into a single segment of the small intestine due to its location or extent of involvement. This can complicate diagnosis and treatment, as symptoms may vary widely and can include abdominal pain, weight loss, and gastrointestinal bleeding. Diagnostic challenges arise from the non-specific nature of these symptoms and the potential for misdiagnosis as benign conditions. Imaging studies, endoscopy, and biopsy are critical for accurate diagnosis, but the rarity of these tumors can lead to delays in detection. The prognosis often depends on the tumor type, stage at diagnosis, and response to treatment, which may include surgery, chemotherapy, or radiation therapy.
Detailed pathology reports, imaging studies, and treatment plans.
Diagnosis and management of small intestine tumors, staging of malignancies.
Ensure clear documentation of tumor characteristics and treatment response.
Endoscopy reports, biopsy results, and clinical notes detailing symptoms.
Evaluation of gastrointestinal symptoms, performing biopsies for suspected malignancies.
Accurate documentation of findings during procedures is crucial for coding.
Used when surgical intervention is required for malignant neoplasm.
Operative reports detailing the procedure and findings.
Oncologists and surgeons must coordinate documentation to ensure accurate coding.
Common symptoms include abdominal pain, unexplained weight loss, gastrointestinal bleeding, and changes in bowel habits. However, symptoms can be non-specific and may overlap with other gastrointestinal conditions.